Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore; Sirpa Leppa; Maria Gomes da Silva; Thomas Relander; Grete Fossum Lauritzsen; Peter De Nully Brown; Antonio Pezzutto; Jeanette K. Doorduijn; Eckhart Weidmann; Michel van Gelder; Achiel Van Hoof; Ilse Christiansen; Unn Merete Fagerli; Hans Hagberg; P. J. Lugtenburg; Jan Walewski; Ka Lung Wu; Hilde Maria Demuynck; Rob Fijnheer; Jacob H. Christensen; Milada Jankovska; Pär L. Josefsson; Hanneke Kluin-Nelemans; Jose Mario Mariz; Mats A. Merup; Thomas Noesslinger; Eric Van den Neste; Josee M. Zijlstra; Georg Hopfinger; V. I. T. Prochazka; Esa Jantunen; Ludmila Boudova; Jose Cabecadas; Andreas Chott; Jan M. A. Delabie; Laurence de Leval; Arjan Diepstra; Marja-Liisa Karjalainen-Lindsberg; Peter Noergaard; Andreas Rosenwald; Grzegorz Rymkiewicz; Christer Sundström; Lorenz Truemper; Gerald Wulf; Lauren Chong; Alyssa Bouska; Lynette Smith; Christian Gisselbrecht; Marita Ziepert; Markus Loeffler; Knut Liestol; Christian Steidl; Randy D. Gascoyne; David W. Scott; Bettina Altmann; Javeed Iqbal; Wing C. Chan; Helle Toldbod

doi:10.1182/blood-2018-99-110429

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore, Sirpa Leppa, Maria Gomes da Silva, Thomas Relander, Grete Fossum Lauritzsen, Peter De Nully Brown, Antonio Pezzutto, Jeanette K. Doorduijn, Eckhart Weidmann, Michel van Gelder, Achiel Van Hoof, Ilse Christiansen, Unn Merete Fagerli, Hans Hagberg, P. J. Lugtenburg, Jan Walewski, Ka Lung Wu, Hilde Maria Demuynck, Rob Fijnheer, Jacob H. ChristensenMilada Jankovska, Pär L. Josefsson, Hanneke Kluin-Nelemans, Jose Mario Mariz, Mats A. Merup, Thomas Noesslinger, Eric Van den Neste, Josee M. Zijlstra, Georg Hopfinger, V. I. T. Prochazka, Esa Jantunen, Ludmila Boudova, Jose Cabecadas, Andreas Chott, Jan M. A. Delabie, Laurence de Leval, Arjan Diepstra, Marja-Liisa Karjalainen-Lindsberg, Peter Noergaard, Andreas Rosenwald, Grzegorz Rymkiewicz, Christer Sundström, Lorenz Truemper, Gerald Wulf, Lauren Chong, Alyssa Bouska, Lynette Smith, Christian Gisselbrecht, Marita Ziepert, Markus Loeffler, Knut Liestol, Christian Steidl, Randy D. Gascoyne, David W. Scott, Bettina Altmann, Javeed Iqbal, Wing C. Chan, Helle Toldbod

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Blood
Volume	132
Issue number	Suppl. 1
Pages (from-to)	998
Number of pages	1
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2018-99-110429
Publication status	Published - Nov 2018
Event	60th ASH Annual Meeting & Exposition - San Diego, United States Duration: 1 Dec 2018 → 4 Dec 2018 Conference number: 60

Conference

Conference	60th ASH Annual Meeting & Exposition
Number	60
Country/Territory	United States
City	San Diego
Period	01/12/2018 → 04/12/2018

Access to Document

10.1182/blood-2018-99-110429

http://www.bloodjournal.org.auh.aub.aau.dk/content/132/Suppl_1/998

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

d'Amore, F., Leppa, S., da Silva, M. G., Relander, T., Lauritzsen, G. F., Brown, P. D. N., Pezzutto, A., Doorduijn, J. K., Weidmann, E., van Gelder, M., Van Hoof, A., Christiansen, I., Fagerli, U. M., Hagberg, H., Lugtenburg, P. J., Walewski, J., Wu, K. L., Demuynck, H. M., Fijnheer, R., ... Toldbod, H. (2018). Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant. Blood, 132(Suppl. 1), 998. https://doi.org/10.1182/blood-2018-99-110429

d'Amore, Francesco ; Leppa, Sirpa ; da Silva, Maria Gomes et al. / Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant. In: Blood. 2018 ; Vol. 132, No. Suppl. 1. pp. 998.

@article{11546baa076046dd84cc11c1e6901d0a,

title = "Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant",

author = "Francesco d'Amore and Sirpa Leppa and {da Silva}, {Maria Gomes} and Thomas Relander and Lauritzsen, {Grete Fossum} and Brown, {Peter De Nully} and Antonio Pezzutto and Doorduijn, {Jeanette K.} and Eckhart Weidmann and {van Gelder}, Michel and {Van Hoof}, Achiel and Ilse Christiansen and Fagerli, {Unn Merete} and Hans Hagberg and Lugtenburg, {P. J.} and Jan Walewski and Wu, {Ka Lung} and Demuynck, {Hilde Maria} and Rob Fijnheer and Christensen, {Jacob H.} and Milada Jankovska and Josefsson, {P{\"a}r L.} and Hanneke Kluin-Nelemans and Mariz, {Jose Mario} and Merup, {Mats A.} and Thomas Noesslinger and {Van den Neste}, Eric and Zijlstra, {Josee M.} and Georg Hopfinger and Prochazka, {V. I. T.} and Esa Jantunen and Ludmila Boudova and Jose Cabecadas and Andreas Chott and Delabie, {Jan M. A.} and {de Leval}, Laurence and Arjan Diepstra and Marja-Liisa Karjalainen-Lindsberg and Peter Noergaard and Andreas Rosenwald and Grzegorz Rymkiewicz and Christer Sundstr{\"o}m and Lorenz Truemper and Gerald Wulf and Lauren Chong and Alyssa Bouska and Lynette Smith and Christian Gisselbrecht and Marita Ziepert and Markus Loeffler and Knut Liestol and Christian Steidl and Gascoyne, {Randy D.} and Scott, {David W.} and Bettina Altmann and Javeed Iqbal and Chan, {Wing C.} and Helle Toldbod",

year = "2018",

month = nov,

doi = "10.1182/blood-2018-99-110429",

language = "English",

volume = "132",

pages = "998",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "Suppl. 1",

note = "60th ASH Annual Meeting & Exposition ; Conference date: 01-12-2018 Through 04-12-2018",

}

d'Amore, F, Leppa, S, da Silva, MG, Relander, T, Lauritzsen, GF, Brown, PDN, Pezzutto, A, Doorduijn, JK, Weidmann, E, van Gelder, M, Van Hoof, A, Christiansen, I, Fagerli, UM, Hagberg, H, Lugtenburg, PJ, Walewski, J, Wu, KL, Demuynck, HM, Fijnheer, R, Christensen, JH, Jankovska, M, Josefsson, PL, Kluin-Nelemans, H, Mariz, JM, Merup, MA, Noesslinger, T, Van den Neste, E, Zijlstra, JM, Hopfinger, G, Prochazka, VIT, Jantunen, E, Boudova, L, Cabecadas, J, Chott, A, Delabie, JMA, de Leval, L, Diepstra, A, Karjalainen-Lindsberg, M-L, Noergaard, P, Rosenwald, A, Rymkiewicz, G, Sundström, C, Truemper, L, Wulf, G, Chong, L, Bouska, A, Smith, L, Gisselbrecht, C, Ziepert, M, Loeffler, M, Liestol, K, Steidl, C, Gascoyne, RD, Scott, DW, Altmann, B, Iqbal, J, Chan, WC & Toldbod, H 2018, 'Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant', Blood, vol. 132, no. Suppl. 1, pp. 998. https://doi.org/10.1182/blood-2018-99-110429

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant. / d'Amore, Francesco; Leppa, Sirpa; da Silva, Maria Gomes et al.
In: Blood, Vol. 132, No. Suppl. 1, 11.2018, p. 998.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

AU - d'Amore, Francesco

AU - Leppa, Sirpa

AU - da Silva, Maria Gomes

AU - Relander, Thomas

AU - Lauritzsen, Grete Fossum

AU - Brown, Peter De Nully

AU - Pezzutto, Antonio

AU - Doorduijn, Jeanette K.

AU - Weidmann, Eckhart

AU - van Gelder, Michel

AU - Van Hoof, Achiel

AU - Christiansen, Ilse

AU - Fagerli, Unn Merete

AU - Hagberg, Hans

AU - Lugtenburg, P. J.

AU - Walewski, Jan

AU - Wu, Ka Lung

AU - Demuynck, Hilde Maria

AU - Fijnheer, Rob

AU - Christensen, Jacob H.

AU - Jankovska, Milada

AU - Josefsson, Pär L.

AU - Kluin-Nelemans, Hanneke

AU - Mariz, Jose Mario

AU - Merup, Mats A.

AU - Noesslinger, Thomas

AU - Van den Neste, Eric

AU - Zijlstra, Josee M.

AU - Hopfinger, Georg

AU - Prochazka, V. I. T.

AU - Jantunen, Esa

AU - Boudova, Ludmila

AU - Cabecadas, Jose

AU - Chott, Andreas

AU - Delabie, Jan M. A.

AU - de Leval, Laurence

AU - Diepstra, Arjan

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Noergaard, Peter

AU - Rosenwald, Andreas

AU - Rymkiewicz, Grzegorz

AU - Sundström, Christer

AU - Truemper, Lorenz

AU - Wulf, Gerald

AU - Chong, Lauren

AU - Bouska, Alyssa

AU - Smith, Lynette

AU - Gisselbrecht, Christian

AU - Ziepert, Marita

AU - Loeffler, Markus

AU - Liestol, Knut

AU - Steidl, Christian

AU - Gascoyne, Randy D.

AU - Scott, David W.

AU - Altmann, Bettina

AU - Iqbal, Javeed

AU - Chan, Wing C.

AU - Toldbod, Helle

N1 - Conference code: 60

PY - 2018/11

Y1 - 2018/11

U2 - 10.1182/blood-2018-99-110429

DO - 10.1182/blood-2018-99-110429

M3 - Conference abstract in journal

SN - 0006-4971

VL - 132

SP - 998

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 60th ASH Annual Meeting & Exposition

Y2 - 1 December 2018 through 4 December 2018

ER -

d'Amore F, Leppa S, da Silva MG, Relander T, Lauritzsen GF, Brown PDN et al. Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant. Blood. 2018 Nov;132(Suppl. 1):998. doi: 10.1182/blood-2018-99-110429